Home > Quotes > ONVO

Organovo Holdings, Inc. Common Stock Quote & Summary Data

Get ONVO Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading ONVO now
Exchange: AMEX
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Organovo Holdings, Inc. Common Stock Intraday Chart

News for ONVO

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 2.84 $ 5.82
Low $ 2.64 $ 1.60

The current last sale of $2.83 is 76.88% Higher thanthe 52 week low.

Company Description (as filed with the SEC)

We are an early commercial stage company focused on developing and commercializing functional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. We intend to introduce a paradigm shift in the approach to the generation of three-dimensional ("3D") human tissues, by utilizing our proprietary platform technology to create human tissue constructs in 3D that mimic native human tissue composition, architecture, and function. We believe we will leverage our highly unique 3D human tissue models to improve the current industry standard cell-based and animal model testing approaches to drug discovery and development by creating 3D tissues constructed solely of human cells.  ... More ...  

Risk Grade

Where does ONVO fit in the risk graph?

Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?